Published in Infect Immun on October 01, 2002
Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol (2005) 0.97
TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis. Am J Pathol (2006) 0.94
Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun (2004) 0.92
IL-4/IL-13 independent goblet cell hyperplasia in experimental helminth infections. BMC Immunol (2008) 0.91
A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation. J Autoimmun (2012) 0.86
Signals for the execution of Th2 effector function. Cytokine (2009) 0.86
Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge. Infect Immun (2004) 0.81
The Biology of Autoimmune Response in the Scurfy Mice that Lack the CD4+Foxp3+ Regulatory T-Cells. Biology (Basel) (2012) 0.76
Role of IL-4Rα during acute schistosomiasis in mice. Parasite Immunol (2014) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Reciprocal control of T helper cell and dendritic cell differentiation. Science (1999) 7.28
Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity (1998) 5.75
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med (2000) 4.37
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest (1999) 4.22
Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity (2000) 3.93
The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol (2000) 3.71
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol (1999) 3.03
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol (2000) 2.89
Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J Immunol (2000) 2.52
Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med (2001) 2.07
NKT cells are phenotypically and functionally diverse. Eur J Immunol (1999) 1.97
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun (1986) 1.71
T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci U S A (1998) 1.58
IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol (2001) 1.33
CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Semin Immunol (2000) 1.32
Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation. J Immunol (2000) 1.31
The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J Immunol (1996) 1.28
Murine eosinophils and IL-1: alpha IL-1 mRNA detection by in situ hybridization. Production and release of IL-1 from peritoneal eosinophils. J Immunol (1990) 1.27
T cell activation and polarization by DC1 and DC2. Curr Top Microbiol Immunol (2000) 1.21
Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur J Immunol (1997) 1.21
Stat6-dependent and -independent pathways for IL-4 production. J Immunol (1999) 1.14
Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J Immunol (2001) 1.07
CD1-mediated immune responses to glycolipids. Curr Opin Immunol (1999) 1.04
Two waves of gamma delta T cells expressing different V delta genes are recruited into schistosome-induced liver granulomas. J Immunol (1995) 1.01
In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis. J Immunol (1987) 0.97
Early interleukin-4: its role in the switch towards a Th2 response and IgE-mediated allergy. Int Arch Allergy Immunol (1999) 0.95
T cells expressing the gamma delta T cell receptor are not required for egg granuloma formation in schistosomiasis. Eur J Immunol (1995) 0.94
Methods Used to Study Immunoregulation of Schistosome Egg Granulomas Methods (1996) 0.93
Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann N Y Acad Sci (1996) 0.93
CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease. J Exp Med (2000) 0.93
Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol Ther (2000) 0.92
Endogenous IL-10 regulates IFN-gamma and IL-5 cytokine production and the granulomatous response in Schistosomiasis mansoni-infected mice. Immunology (1998) 0.91
Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation. J Immunol (1999) 0.89
Down-regulation of interleukin-12, interleukin-12R expression/activity mediates the switch from Th1 to Th2 granuloma response during murine Schistosomiasis mansoni. Scand J Immunol (2000) 0.86
Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice. J Immunol (1998) 0.86
Macrophages isolated from liver granulomas of murine Schistosoma mansoni synthesize predominantly TxA2 during the acute and chronic phases of infection. J Immunol (1988) 0.83
The development of CD4+ T effector cells during the type 2 immune response. Immunol Res (1999) 0.76
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology (2002) 2.27
Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol (2004) 1.92
Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development (2005) 1.90
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis (2009) 1.77
Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol (2003) 1.75
Intestinal helminths protect in a murine model of asthma. J Immunol (2006) 1.64
Helminths as governors of immune-mediated inflammation. Int J Parasitol (2006) 1.59
Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci (2012) 1.47
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35
Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am J Physiol Gastrointest Liver Physiol (2006) 1.28
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest (2003) 1.27
Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol (2012) 1.24
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis (2009) 1.17
Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol (2012) 1.17
Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J Immunol (2006) 1.15
Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12
Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis (2005) 1.11
Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med (2006) 1.10
Advances in the pathogenesis and treatment of IBD. Clin Immunol (2009) 1.10
Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med (2007) 1.09
Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol (2010) 1.09
The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med (2002) 1.05
Substance P regulates Th1-type colitis in IL-10 knockout mice. J Immunol (2003) 1.04
Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect Immun (2008) 1.02
Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis. J Immunol (2013) 0.97
Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol (2005) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
IL-18 and IL-12 signal through the NF-kappa B pathway to induce NK-1R expression on T cells. J Immunol (2003) 0.94
Helminths and the modulation of mucosal inflammation. Curr Opin Gastroenterol (2005) 0.94
Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol (2002) 0.93
Helminthic therapy: using worms to treat immune-mediated disease. Adv Exp Med Biol (2009) 0.91
CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis. Am J Physiol Gastrointest Liver Physiol (2004) 0.91
Cutting edge: hemokinin has substance P-like function and expression in inflammation. J Immunol (2004) 0.89
Substance P receptor mediated maintenance of chronic inflammation in EAE. J Neuroimmunol (2006) 0.88
IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J Immunol (2005) 0.87
TGF-beta regulates T-cell neurokinin-1 receptor internalization and function. Proc Natl Acad Sci U S A (2010) 0.87
Immunologic and molecular mechanisms in inflammatory bowel disease. Surg Clin North Am (2007) 0.86
Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc (2013) 0.86
CD4+ TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas. J Immunol (2002) 0.86
ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes. J Immunol (2008) 0.86
Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease. Inflamm Bowel Dis (2012) 0.85
Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol (2005) 0.84
Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun (2008) 0.83
Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol (2010) 0.83
Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol (2010) 0.83
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cell Immunol (2009) 0.83
Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma. Am J Respir Cell Mol Biol (2009) 0.83
T cell substance P receptor governs antigen-elicited IFN-gamma production. Am J Physiol Gastrointest Liver Physiol (2002) 0.82
Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells. PLoS One (2009) 0.82
Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis (2003) 0.81
Why Trichuris suis should prove safe for use in inflammatory bowel diseases. Inflamm Bowel Dis (2005) 0.81
Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine gamma-herpesvirus 68. J Immunol (2003) 0.81
Th2-type granuloma development in acute murine schistosomiasis is only partly dependent on CD4+ T cells as the source of IL-4. Eur J Immunol (2002) 0.80
Therapeutic colonization with Trichuris suis. Arch Pathol Lab Med (2006) 0.78
IL-4 inhibits vasoactive intestinal peptide production by macrophages. Am J Physiol Gastrointest Liver Physiol (2002) 0.78